Apoptosis in Alzheimer disease: a mathematical improbability
Xiongwei Zhu1, Arun K Raina, George Perry
1Department of Pathology, Case Western Reserve University, 2103 Cornell Road, Cleveland, Ohio 44106 USA.
Current Alzheimer Research
|October 5, 2006
Summary
Alzheimer disease involves neuronal death, but the chronic, slow progression makes apoptosis unlikely. Researchers are exploring the precise mechanisms of neuronal demise in Alzheimer's disease.
Area of Science:
- Neuroscience
- Pathology
Background:
- Alzheimer disease (AD) is characterized by neuronal dysfunction and death.
- Understanding the mechanisms of neuronal death is crucial for developing effective AD therapeutics.
- Neuronal death pathways, including apoptosis and necrosis, are key areas of investigation.
Purpose of the Study:
- To critically evaluate the role of apoptosis in Alzheimer disease.
- To investigate the precise mechanisms of neuronal death in the context of AD progression.
Main Methods:
- Review of existing literature on Alzheimer disease pathology and cell death mechanisms.
- Analysis of the temporal dynamics and scale of neuronal death in AD.
- Comparison of observed neuronal death characteristics with apoptotic and necrotic processes.
Main Results:
- While some pro-apoptotic factors are present in AD, the overall process does not align with classical apoptosis.
- The chronic and slow nature of neuronal death in AD makes apoptosis a mathematically improbable mechanism.
- Neuronal death in AD is likely a complex process distinct from rapid, controlled apoptotic cell death.
Conclusions:
- The term 'apoptosis' is likely misapplied to neuronal death in Alzheimer disease.
- Further research is needed to elucidate the specific pathways driving neuronal demise in AD.
- A deeper understanding of AD-specific neuronal death mechanisms is essential for targeted therapeutic interventions.
More Related Videos
Related Concept Videos
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:30Apoptosis
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...